MedTrace Logo

Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children

NCT00308906 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 166

Last updated 2016-02-02

No results posted yet for this study

Summary

The purposes of this study are to identify potential gene and protein markers of aminoglycoside-induced kidney injury in infants, children and adolescents treated with aminoglycoside antibiotics.

Conditions

Interventions

DRUG

aminoglycoside

Aminoglycosides will be administered and monitored as part of the routine standard of care for the subject.

Sponsors & Collaborators

  • University of Louisville

    collaborator OTHER

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Mary Jayne Kennedy, Pharm.D. · Virginia Commonwealth University

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00308906 on ClinicalTrials.gov